AbbVie Inc (NYSE:ABBV)

93.17
Delayed Data
As of Apr 23
 +0.57 / +0.62%
Today’s Change
64.26
Today|||52-Week Range
125.86
-3.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line1.7B1.9B1.6B52.0M
 
 
 
 
 
Depreciation374.0M379.0M379.0M369.0M
 
 
 
 
 
Total Other Cash Flow299.0M251.0M297.0M2.3B
 
 
 
 
 
Funds From Operations2.4B2.5B2.3B2.7B
 
 
 
 
 
Funds From/For Other Operating Expenses282.0M542.0M-964.0M131.0M
 
 
 
 
 
Net Cash Flow - Operating Activities2.1B2.0B3.3B2.6B
 
 
 
 
 
 
InvestingIncrease In Investments-970.0M-421.0M-447.0M-392.0M
 
 
 
 
 
Decrease In Investments444.0M902.0M544.0M903.0M
 
 
 
 
 
Capital Expenditures-95.0M-126.0M-126.0M-182.0M
 
 
 
 
 
Other Investing - Uses-63.0M-37.0M-80.0M-128.0M
 
 
 
 
 
Net Cash Flow Investing-684.0M318.0M-109.0M201.0M
 
 
 
 
 
 
FinancingShort Term Borrowings23.0M0.00400.0M-401.0M
 
 
 
 
Long Term Borrowings----0.000.00--
Long Term Debt Reduction-6.0M-7.0M-5.0M-7.0M
 
 
 
 
 
Net Proceeds Stock Sale85.0M64.0M65.0M40.0M
 
 
 
 
 
Common Preferred Redeemed-895.0M-5.0M-5.0M-505.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-1.0B-1.0B-1.0B-1.0B
 
 
 
 
 
Other Sources - Financing26.0M-8.0M29.0M-25.0M
 
 
 
 
 
Other Uses - Financing------0.00--
Net Cash Flow - Financing-1.8B-980.0M-810.0M-1.9B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash16.0M7.0M6.0M0.00
 
 
 
 
 
Net Change In Cash-376.0M1.3B2.4B857.0M